Natco Pharma Ltd

NSE: NATCOPHARM · BSE: 524816 · Pharmaceuticals & Biotechnology · 49 announcements

Natco Pharma Ltd news stories on ALFA NewsRead the news →

Share price: ₹808.95
Market cap: ₹15,869 Cr
Revenue (annual): ₹4,078 Cr
Net profit (annual): ₹1,418 Cr
P/E (TTM): 13.9×Sector 43.8×
Promoter holding: 46.22%-3.20% QoQ
FII holding: 15.37%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 2 Capital Structure Change 2 Share Pledge 1 Product Launch 1 Employee Stock Options 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

30 Oct 2026 10:42 IST BSE

Capital Structure Change

Natco Pharma Capital Structure Change

Natco Pharma allotted 5,86,666 equity shares to promoter Venkaiah Chowdary Nannapaneni via its rights issue, valued at ~₹44 Crore. This lifts his stake to 14.60%.

Value: ₹44.00 Cr

Open announcement → Read the filing ↗

22 Oct 2026 13:22 IST NSE

Capital Structure Change

Natco Pharma Capital Structure Change

Natco Pharma's ₹1,279.4 Crore rights issue closed on October 22, 2026. Shares were priced at ₹750 each on a ₹2 face value.

Value: ₹1,279 Cr

Open announcement → Read the filing ↗